Performance Food Group (PFGC) Form 144 Reports 1,277-Share Sale

Rhea-AI Filing Summary

Performance Food Group Company (PFGC) Form 144 notice shows a proposed sale of 1,277 common shares through Morgan Stanley Smith Barney on the NYSE, with an aggregate market value of $128,938.69 and an approximate sale date of 08/27/2025. The shares were acquired on 08/25/2025 under an RSA from the issuer and payment is recorded as made on that acquisition date.

The filing also discloses recent Rule 10b5-1 plan sales by Erika T. Davis totaling 15,365 shares sold during the past three months on dates 05/29/2025 (8,200 shares, $735,680.22), 08/19/2025 (1,529 shares, $152,365.00), 08/20/2025 (4,316 shares, $433,836.98) and 08/25/2025 (1,320 shares, $134,170.21). The filer certifies no undisclosed material adverse information and references Rule 10b5-1 plan adoption where applicable.

Positive

• Specific transaction details are provided: share counts, aggregate market values, broker, and approximate sale date for the proposed sale
• Prior 10b5-1 plan sales are itemized with dates and gross proceeds, improving transparency about recent insider liquidity
• Acquisition method for the scheduled sale is specified as an RSA with matching acquisition and payment dates

Negative

• Issuer contact details and some filer contact fields are not present in the provided extract, limiting independent verification
• Substantial insider sales occurred in the past three months (15,365 shares total), which could be viewed as notable insider liquidity

Insights

Securities Analyst

TL;DR: Insider sales under a 10b5-1 plan and a listed RSA-derived sale totaling 1,277 shares are disclosed; recent aggregated sales equal 15,365 shares.

The filing documents a proposed sale of 1,277 shares on 08/27/2025 acquired via RSA on 08/25/2025 and multiple executed 10b5-1 plan sales by Erika T. Davis during the prior three months. The analyst perspective focuses on the quantum and timing of insider liquidity: 15,365 shares sold in the period with disclosed gross proceeds for each transaction, and the upcoming sale routed through a major broker. The filing is procedural and follows Rule 144 notice requirements; it does not provide context on holding percentages or impact on outstanding float.

Corporate Governance Expert

TL;DR: Disclosure is compliant: sale details, acquisition method (RSA), and 10b5-1 sales are listed; no material undisclosed information claimed by signer.

From a governance standpoint, the notice supplies required transaction-level detail: class, broker, share counts, market values, acquisition dates, and reliance on Rule 10b5-1 where applicable. The signer affirms absence of undisclosed material adverse information, consistent with Form 144 attestation norms. The document omits issuer address and some filer contact fields in the provided extract, which limits completeness for third-party verification but does not negate the transactional disclosures shown.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	1277	128938.69	156519106	08/27/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	08/25/2025	RSA	Issuer			1277	08/25/2025	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales for ERIKA T. DAVIS 12500 West Creek Parkway Richmond VA 23238	Common	08/25/2025	1320	134170.21
10b5-1 Sales for ERIKA T. DAVIS 12500 West Creek Parkway Richmond VA 23238	Common	08/20/2025	4316	433836.98
10b5-1 Sales for ERIKA T. DAVIS 12500 West Creek Parkway Richmond VA 23238	Common	08/19/2025	1529	152365.00
10b5-1 Sales for ERIKA T. DAVIS 12500 West Creek Parkway Richmond VA 23238	Common	05/29/2025	8200	735680.22

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the PFGC Form 144 disclose about the scheduled sale?

The notice discloses a proposed sale of 1,277 common shares on 08/27/2025 via Morgan Stanley Smith Barney with an aggregate market value of $128,938.69.

How were the 1,277 shares acquired according to the filing?

The filing states the shares were acquired on 08/25/2025 under an RSA from the issuer and payment is recorded as made on that date.

What insider sales occurred in the past three months for PFGC?

Erika T. Davis executed Rule 10b5-1 sales totaling 15,365 shares on 05/29/2025 (8,200 shares, $735,680.22), 08/19/2025 (1,529 shares, $152,365.00), 08/20/2025 (4,316 shares, $433,836.98), and 08/25/2025 (1,320 shares, $134,170.21).

Does the Form 144 indicate reliance on a 10b5-1 trading plan?

Yes; the filing lists previous sales labeled as 10b5-1 Sales and the remarks reference plan adoption or instruction dates where applicable.

Does the filer certify there is no undisclosed material adverse information?

Yes; the signer represents by signing that they do not know any material adverse information about the issuer that has not been publicly disclosed.